Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials.
about
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 MeetingTreatment of colorectal cancer in the elderlyReasons for and against participation in studies of medicinal therapies for women with breast cancer: a debateAgeism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leadsSystematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase InhibitorsRandomized Trial of a Web-Based Intervention to Address Barriers to Clinical TrialsSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsThe relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsSurvival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaParticipation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retentionCancer in the elderly.Long-term outcomes and propensity score matching analysis: rectal cancer resection for patients with elevated preoperative risk.Research participation among older adults with mobility limitation.Reasons for participating in randomised controlled trials: conditional altruism and considerations for self.Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Blood transfusion in elderly patients with chronic anemia: a qualitative analysis of the general practitioners' attitudes.Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendationsAge disparity in the dissemination of imatinib for treating chronic myeloid leukemiaApplication of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.Persistent mobility disability after neurotoxic chemotherapyExclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study.Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experienceBridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriersBarriers to recruitment of rural patients in cancer clinical trials.Treatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and IrelandUndertreatment of breast cancer in the elderly.Insecurities of women regarding breast cancer research: a qualitative study.External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.Automated determination of metastases in unstructured radiology reports for eligibility screening in oncology clinical trialsTrends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?
P2860
Q25257182-EFE37733-69A7-4D40-9086-413AE2614624Q26747628-31FBDF43-8F26-4CB4-846C-0ED3BB48B516Q26781457-874CD9F6-A49A-403E-B667-EF60D60B5828Q26851379-E998029A-DE8F-401A-BA0D-B54B16C596F1Q26853395-1284C761-AD8E-444D-A174-F61933AF772FQ26863383-E358FD10-0081-4B90-9ABE-F361A2A34AE9Q27313405-3A5E714E-5E50-4D91-A624-6F793E55B470Q28710019-3B114309-5AC0-4732-A05C-4FF207D607CCQ30224746-8F279AF0-5128-41CA-A577-DC216C96ED16Q30557206-11ED5CDF-5DCE-49DB-9486-12939D9B2328Q31057366-081584E8-5025-4B6D-9E63-0F2D5F8CBA84Q33412728-B98DF461-53C7-4D22-A883-2CA0E57B9A5FQ33491875-76283230-3D55-4FE5-8F50-5AD1E3D3C784Q33614295-158FB467-8FD9-47A6-9FBF-FFBFC6964F0AQ33649000-FE6D1C24-D888-461B-9DD4-121D959737F7Q33673916-76810E03-F71A-42D2-AFD8-A2A3637ED1D0Q33764230-6463C59C-3EA4-470D-9675-23844DADB279Q33816617-71007113-629C-4F87-A0FE-849509CCE2C0Q33865329-1795A6E3-5829-43F7-B8F5-6B49A84AE612Q33892562-2E5B7056-7E59-4A54-92D3-C96DA345C121Q33899433-58BC8870-4B14-4150-B00B-F97DD50CFF80Q33946721-572834E7-C4D1-431D-91AA-E9A1986D09CEQ33947761-3057C677-A14B-49F7-B19F-83461FF6A8BBQ34008107-2464F2B1-435E-489B-9023-5049123A1729Q34031134-A7D46E49-8BF0-4437-B233-6A3A9075EA99Q34032508-4D87201B-1323-4076-93CF-445A5EA35422Q34224032-211C1797-B7AA-47CF-9D12-A8835A3E753FQ34259315-C0A05283-3836-470D-BD12-0365ACEF36F4Q34359352-76ED2633-ACF3-42DE-A2B8-8E196481AF71Q34730649-78F5E82A-4225-4ABC-8DC5-E51BA5FDB5A7Q34801461-6E52A081-69E3-455D-8182-73BC9E36CB88Q34916145-9A457955-CA7E-4AB4-BDC7-1F19D7A0F0CFQ34974911-49B279E0-A34F-4060-BB83-70180863D0C8Q35043918-21E1278C-D2D6-4BCC-82A9-D55637605EE4Q35051048-E2C769B2-A110-4EF8-8041-7B1A28E7E73CQ35061328-CE872CA3-81F7-4E7A-97A8-4EF533EEFF36Q35125211-A28148C7-2C06-47D7-8A98-95B11A0074B8Q35174686-49AE5295-AB6F-4F0F-8616-7754D9FCDD48Q35236068-760C689F-58B9-406B-9CEF-44F3E046C1E5Q35611941-D7D49490-6ACC-46EF-8AEC-196967058E31
P2860
Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systematic review of barriers ...... h cancer onto clinical trials.
@ast
Systematic review of barriers ...... h cancer onto clinical trials.
@en
type
label
Systematic review of barriers ...... h cancer onto clinical trials.
@ast
Systematic review of barriers ...... h cancer onto clinical trials.
@en
prefLabel
Systematic review of barriers ...... h cancer onto clinical trials.
@ast
Systematic review of barriers ...... h cancer onto clinical trials.
@en
P2093
P356
P1476
Systematic review of barriers ...... h cancer onto clinical trials.
@en
P2093
Carol A Townsley
Lillian L Siu
Rita Selby
P304
P356
10.1200/JCO.2005.00.141
P407
P577
2005-05-01T00:00:00Z